A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.Elizabeth M. Adams, Paul H. Plötz, Bryce Thornton et al.|PubMed|1999Cited by 58
Failure of low‐dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment‐refractory rheumatoid arthritisKeith S. Kanik, Ronald L. Wilder, Cheryl Yarboro et al.|Arthritis & Rheumatism|1996Cited by 26